Cas 890040-26-3,L-Alanine, 3-(4-morpholinylsulfonyl)-N-[(phenylmethoxy)carbonyl]-, phenylmethyl ester

890040-26-3

Post Buying Request

Basic information

Product Name: L-Alanine, 3-(4-morpholinylsulfonyl)-N-[(phenylmethoxy)carbonyl]-, phenylmethyl ester
Synonyms:
CAS NO:890040-26-3
Molecular Formula: C22H26N2O7S
Molecular Weight: 462.524
EINECS: N/A
Product Categories: N/A

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: L-Alanine, 3-(4-morpholinylsulfonyl)-N-[(phenylmethoxy)carbonyl]-, phenylmethyl ester(CAS DataBase Reference)
NIST Chemistry Reference: L-Alanine, 3-(4-morpholinylsulfonyl)-N-[(phenylmethoxy)carbonyl]-, phenylmethyl ester(890040-26-3)
EPA Substance Registry System: L-Alanine, 3-(4-morpholinylsulfonyl)-N-[(phenylmethoxy)carbonyl]-, phenylmethyl ester(890040-26-3)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 890040-26-3(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

890040-26-3 Suppliers

Recommended suppliers

890040-26-3 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 890040-26-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,9,0,0,4 and 0 respectively; the second part has 2 digits, 2 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 890040-26:
(8*8)+(7*9)+(6*0)+(5*0)+(4*4)+(3*0)+(2*2)+(1*6)=153
153 % 10 = 3
So 890040-26-3 is a valid CAS Registry Number.

890040-26-3Upstream product

890040-26-3Downstream Products

890040-26-3Relevant academic research and scientific papers

SULFONAMIDE COMPOUNDS AS CYSTEINE PROTEASE INHIBITORS

-

Page/Page column 74, (2008/06/13)

The present invention is directed to compounds of formula ( I ) that are inhibitors of cysteine proteases, in particular, cathepsins B, K, L, F, and S and are therefore useful in treating diseases mediated by these proteases. The present invention is directed to pharmaceutical compositions comprising these compounds and processes for preparing them. Wherein R3 is-alkylene-SO2NR5R6.

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 890040-26-3